• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care.
【24h】

Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care.

机译：合并注意缺陷障碍对在管理治疗中治疗抑郁症成人的直接医疗费用的影响。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: To assess the impact of comorbid attention deficit disorder (ADD) on the direct medical costs of treating adults with depression in a mixed-model health maintenance organization. METHOD: Annual mean and marginal health care costs were calculated for adults who were continuously enrolled at Group Health Cooperative during 2001 and who were diagnosed with depression, ADD, or both ADD and depression according to ICD-9-CM criteria during 2001. RESULTS: Of 249,874 adults continuously enrolled during 2001, 17,792 (7.1%) were diagnosed with depression, 1023 (0.4%) were diagnosed with ADD, and 454 (0.2%) were diagnosed with both depression and ADD. The mean total annual cost for an adult with a diagnosis of depression in 2001 exceeded that for the average adult enrolled in Group Health by 109% (Dollars 6029 vs. Dollars 2880). Of the Dollars 6029 mean total annual cost for treating an adult with a diagnosis of depression, Dollars 1872 (31%) was specifically attributable to depression. The presence ofcomorbid ADD resulted in ADD- and depression-attributed marginal costs approximately 29% higher than the costs specifically attributed to depression alone (Dollars 2418 vs. Dollars 1872). In fact, among patients with a diagnosis of ADD and depression, ADD- and depression-attributed costs approached the mean total cost of health care in the sample as a whole (Dollars 2880). CONCLUSION: Depression is associated with high direct medical costs. The marginal costs of treating comorbid depression and ADD substantially exceed those of treating depression alone. These results underline the importance of considering the costs of comorbidities in estimating the economic burden of depression and developing cost-effective disease-management strategies.
机译：目的：评估混合型健康维持组织中共病注意缺陷障碍（ADD）对治疗成年人抑郁症的直接医疗费用的影响。方法：计算2001年连续参加团体健康合作社并根据ICD-9-CM标准被诊断为患有抑郁症，ADD或ADD和抑郁症的成年人的年平均和边际医疗保健费用。结果：在2001年连续登记的249874名成年人中，诊断出患有抑郁症的人数为17,792（7.1％），诊断为ADD的人数为1023（0.4％），诊断为抑郁症和ADD的人数为454（0.2％）。 2001年诊断出患有抑郁症的成年人的年均总费用比参加团体健康活动的成年人的平均年均费用高109％（美元6029对美元2880）。在6029美元的平均年治疗患有抑郁症的成年人的总费用中，1872美元（31％）专门归因于抑郁症。共病ADD的存在导致与ADD和抑郁相关的边际成本比专门归因于抑郁的成本高约29％（Dollars 2418 vs. Dollars 1872）。实际上，在诊断为ADD和抑郁症的患者中，整个样本中ADD和抑郁症引起的费用接近平均医疗保健总费用（Dollars 2880）。结论：抑郁症与高额直接医疗费用有关。治疗合并症和ADD的边际成本大大超过仅治疗抑郁症的边际成本。这些结果强调了在评估抑郁症的经济负担和制定具有成本效益的疾病管理策略时考虑合并症成本的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号